The Cancer Risk Management Lung Cancer Model
Principal Investigator
Name
Anthony Miller
Degrees
MD, FRCP
Institution
University of Toronto
Position Title
Professor Emeritus
Email
About this CDAS Project
Study
NLST
(Learn more about this study)
Project ID
NLST-4
Initial CDAS Request Approval
Dec 7, 2012
Title
The Cancer Risk Management Lung Cancer Model
Summary
A microsimulation model using Canadian data has been developed to aid in policy development for and cost-effectiveness of interventions for Cancer Control in Canada. The initial model for lung cancer utilizes Canadian smoking, radon exposure, cost and treatment data. An initial attempt has been made using published data on the NLST to model the impact of low dose computerised tomography (LDCT) screening for lung cancer. We have been able to replicate the results of NLST, but wish to procure additional data to expand the model to encompass annual and or biennial LDCT screening. A particular requirement is to understand how long after the third screen in NLST the incidence of lung cancer returned to a baseline level (inferred from the Chest X-Ray control arm in NLST and published data on Chest X-ray screening in the PLCO trial). We are interested in evaluating different age and gender bands, and also the histologic types. Once the model has been refined, it will be utilized for providing back ground information for lung cancer control, comparing different approaches to reducing lung cancer mortality in Canada.
Aims
To model the effect of low dose computerized (LDCT) screening in Canada on lung cancer mortality
To evaluate the potential cost-effectiveness of annual or biennial continuous LDCT screening on defined high-risk populations.
Collaborators
Dr William Evans, McMaster University, Ontario, Canada
Dr Michael Wolfson, Ottawa University, Ontario, Canada
Mr William Flanagan, Statistics Canada, Ottawa, Ontario
Dr John Goffin, McMaster University, Ontario, Canada
Dr Gina Lockwood, Canadian Partnership against Cancer, Toronto, Ontario, Canada
Related Publications
-
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.
Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC
Curr Oncol. 2016 Jun; Volume 23 (Issue 3): Pages e179-87 PUBMED -
Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK
JAMA Oncol. 2015 Jul; Volume [Epub ahead of print]: Pages [Epub ahead of print] PUBMED -
Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
Fitzgerald NR, Flanagan WM, Evans WK, Miller AB, Canadian Partnership against Cancer (CPAC) Cancer Risk Management (CRM) Lung Cancer Working
Scand J Work Environ Health. 2015 Jul; Volume 41 (Issue 4): Pages 407-12 PUBMED -
Performance of the cancer risk management model lung cancer screening module.
Flanagan WM, Evans WK, Fitzgerald NR, Goffin JR, Miller AB, Wolfson MC
Health Rep. 2015 May; Volume 26 (Issue 5): Pages 11-8 PUBMED